In ovarian cancer, tumor cell- and TAM-derived CCL22 contributed to tumor growth via stimulation of Treg tumor infiltration, which was associated with reduced survival through suppression of tumor-specific T cell immunity [122]. Here, CCL22 is linked to neoplasm.